CHNQD-03005 is an orally active anti-inflammatory agent. CHNQD-03005 inhibits the expression of iNOS and COX-2, reduces inflammatory signal transduction, suppresses NO production, and downregulates the pro-inflammatory cytokines TNF-alpha, IL-6 and IL-1beta. CHNQD-03005 can be used in the research of inflammatory diseases such as colitis[1].
Molecular Weight:
512.55
Formula:
C31H28O7
Target:
COX,Interleukin Related,NO Synthase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
